Form 8-K · Current Report · Filed 2026-07-01
McKesson Appoints New Chief Strategy Officer
On June 29, 2026, McKesson Corporation announced the retirement of Thomas L.
- Filer
- McKesson Corporation MCK · NYSE
- Filed
- Accession
- 0000927653-26-000185
- CIK
- 0000927653
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
Rodgers, Executive Vice President and Chief Strategy and Business Development Officer, effective August 1, 2026. To ensure a smooth transition, Ramesh Srinivasan has been appointed as the new Executive Vice President and Chief Strategy Officer, also effective August 1, 2026. This transition is part of a planned succession strategy to maintain continuity in the company's strategic direction.
Items reported
Reported Item
Market reaction
Close before filing
$755.60
Next session
+4.1%
Since filing
+13.3%
Latest close
$856.19
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MCK reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, MCK insiders reported 103 Form 4 transactions — net selling of $44.4M.
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Never miss another MCK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.